RxDoctor Payments Data

Christine Carter, PA

Physician Assistant · Round Rock, TXNPI 1912590407

Payments from drug & device makers

$3,730in general payments, 2019–2025

Across 179 payments — averaging $20.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$676
  • Inspire Medical Systems, Inc.$580
  • GSK$437
  • United Therapeutics Corporation$315
  • Boehringer Ingelheim$291
  • Amgen$181
  • plus $1K from 24 others

What the payments were for

  • Food & beverage$3,730100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,730 in reported general payments places this provider in the 85th percentile of 8,308 physician assistant providers in Texas.

See all physician assistant providers in Texas

Medicare billing

Part B allowed, 2024
$19,176
Medicare patients
251
Services billed
389

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter101$82,026
Breztri AerosphereBudesonide/Glycopyr/Formoterol57$37,690
Stiolto RespimatTiotropium Br/Olodaterol Hcl34$20,377
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr27$19,955
Spiriva HandihalerTiotropium Bromide21$11,815
SymbicortBudesonide/Formoterol Fumarate22$5,718
Bevespi AerosphereGlycopyrrolate/Formoterol Fum12$5,718
Advair HfaFluticasone Propion/Salmeterol16$4,894
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$4,318
Albuterol Sulfate HfaAlbuterol Sulfate81$3,125
Azithromycin31$361
Montelukast Sodium28$257
Methylprednisolone12$62
Trazodone Hcl14$62
Prednisone17$61

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Anoro Ellipta$437$101,981128 claims
AstraZenecaBreztri Aerosphere, Symbicort, Bevespi Aerosphere$676$49,12691 claims
Boehringer IngelheimStiolto Respimat$291$20,37734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 8,308 physician assistant providers in Texas.

Other physician assistant in Round Rock

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →